<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01076387</url>
  </required_header>
  <id_info>
    <org_study_id>10-016</org_study_id>
    <nct_id>NCT01076387</nct_id>
  </id_info>
  <brief_title>Randomized Trial Comparing Robotic and Open Radical Cystectomy</brief_title>
  <official_title>A Prospective, Randomized Trial Comparing Robotic and Open Radical Cystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if using robotic surgical technology during bladder
      cancer surgery helps to reduce complications during and after the surgery. The removal of the
      bladder and lymph nodes will be done by a robotic or by an open technique. It may be a
      Robotic-assisted Radical Cystectomy (RARC) and Pelvic Lymph Node Dissection. Or it may be an
      Open Radical Cystectomy (ORC) and Pelvic Lymph Node Dissection.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 2010</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare surgical complications of robotic-assisted radical cystectomy and open radical cystectomy.</measure>
    <time_frame>intraoperative and 90-day postoperative period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To examine clinical and pathological outcomes of robotic-assisted radical cystectomy and open radical cystectomy.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-operative performance (surgical time, blood loss)</measure>
    <time_frame>time from anesthesia induction to final skin closure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pathologic findings, including the stage specific, soft tissue surgical margin rate and number of lymph nodes removed.</measure>
    <time_frame>1.5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bladder cancer recurrence (local, upper tract and distant disease)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications grade 2-5</measure>
    <time_frame>2 years</time_frame>
    <description>A secondary analysis will be used to determine if the total burden of grade 2-5 complications in the robotic arm is different from the open arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication grade 3-5</measure>
    <time_frame>2 years</time_frame>
    <description>Determine if there is a difference in either the number of patients with grade 3-5 complication or the total number of grade 3-5 complication in the two arms of the study.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">124</enrollment>
  <condition>Bladder Cancer</condition>
  <arm_group>
    <arm_group_label>open radical cystectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This is a prospective, randomized study designed to compare two techniques of radical cystectomy with PLND (open and robotic) for bladder cancer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>robotic-assisted radical cystectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This is a prospective, randomized study designed to compare two techniques of radical cystectomy with PLND (open and robotic) for bladder cancer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open radical cystectomy</intervention_name>
    <description>Open radical cystectomy, pelvic lymph node dissection and open urinary diversion.</description>
    <arm_group_label>open radical cystectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>robotic-assisted radical cystectomy</intervention_name>
    <description>Robotic radical cystectomy, pelvic lymph node dissection and open urinary diversion. Robotic radical cystectomy is routinely performed by robotically trained and experienced minimally invasive surgeons.</description>
    <arm_group_label>robotic-assisted radical cystectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years.

          -  Scheduled for radical cystectomy at MSKCC

        Exclusion Criteria:

          -  Prior pelvic or abdominal radiation therapy;

          -  Prior extensive open abdominal surgery, defined by the discretion of the attending
             surgeon

          -  Any clinical contraindication for Trendelenburg positioning
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent Laudone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org/mskcc/html/44.cfm</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2010</study_first_submitted>
  <study_first_submitted_qc>February 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2010</study_first_posted>
  <last_update_submitted>February 23, 2018</last_update_submitted>
  <last_update_submitted_qc>February 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bladder</keyword>
  <keyword>Cystectomy</keyword>
  <keyword>Robotic</keyword>
  <keyword>Open Radical</keyword>
  <keyword>10-016</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

